The Impact of Universal Hepatitis B Vaccinations | Conscious Pharmacist Podcast

The Advisory Committee on Immunization Practices (ACIP) recommends vaccination of adults at risk for HBV infection, including universal vaccination of adults in settings in which a high proportion have risk factors for HBV infection and vaccination of adults requesting protection from HBV without acknowledgment of a specific risk factor. Michelle Sherman, RPh., is a pharmacist expert in HIV & HEP-C treatment protocols & is the host of the Conscious Pharmacist Podcast. Michelle is the special co-host of today's discussion on the proposed impact of universal Hepatitis B Vaccinations. About our guest: Catherine Stevenson is Director of Corporate Strategy at Dynavax Technologies, a California-based biotechnology company which has developed and commercialized a 2-dose Hepatitis-B vaccine. With a Masters in Health and Science Policy, her background spans over 10 years of working in biotechnology, non-profits, and scientific research. Referenced Journal Articles: Stevenson C, Youn JH, Hayney MS, David C. Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine. Hum Vaccin Immunother. 2021 Stevenson C, de la Rosa G, Anderson CS, Murphy PS, Capece T, Kim M, Elliott MR. Essential role of Elmo1 in Dock2-dependent lymphocyte migration. J Immunol. 2014 Jun 15;192(12):6062-70. Bradel-Tretheway BG, Mattiacio JL, Krasnoselsky A, Stevenson C, Purdy D, Dewhurst S, Katze MG. Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors. J Virol. 2011 Sep;85(17):8569-81. Zhou T, Zheng A, Baxa U, Chuang GY, Georgiev IS, Kong R, O'Dell S, Shahzad-Ul-Hussan S, Shen CH, Tsybovsky Y, Bailer RT, Gift SK, Louder MK, McKee K, Rawi R, Stevenson CH, Stewart-Jones GBE, Taft JD, Waltari E, Yang Y, Zhang B, Shivatare SS, Shivatare VS, Lee CD, Wu CY; NISC Comparative Sequencing Program, Mullikin JC, Bewley CA, Burton DR, Polonis VR, Shapiro L, Wong CH, Mascola JR, Kwong PD, Wu X. A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope. Immunity. 2018 Mar 20;48(3):500-513.e6. Contributing Posts: Stevenson, C, P Peeples. “Real-world evidence and value-based contracting – swipe left or swipe right?” https://www.healtheconomics.com/blog/2019/02/real-world-evidence-and-value-based-contracting-swipe-left-or-swipe-right/. Stevenson, C, P Peeples. “Pharmacy Benefit Managers: A Mechanism for Containing Costs or a Contributor to Rising Drug Prices?” L https://www.healtheconomics.com/industry-news/pharmacy-benefit-managers-a-mechanism-for-containing-costs-or-a-contributor-to-rising-drug-prices. Learn more about your ad choices. Visit megaphone.fm/adchoices